Lee's Pharmaceutical Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SEHK:950 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 Sep 24	BuyHK$66,455	Wanee Leelalertsuphakun	Individual	56,500	HK$1.18
09 Jul 24	BuyHK$57,000	Wanee Leelalertsuphakun	Individual	50,000	HK$1.14
08 Jul 24	BuyHK$58,775	Wanee Leelalertsuphakun	Individual	52,000	HK$1.13
28 Jun 24	BuyHK$116,500	Wanee Leelalertsuphakun	Individual	100,000	HK$1.17
19 Jun 24	BuyHK$120,000	Wanee Leelalertsuphakun	Individual	100,000	HK$1.20
17 Jun 24	BuyHK$82,925	Wanee Leelalertsuphakun	Individual	72,500	HK$1.14
11 Jun 24	BuyHK$9,075	Wanee Leelalertsuphakun	Individual	7,500	HK$1.21
07 Jun 24	BuyHK$61,000	Wanee Leelalertsuphakun	Individual	50,000	HK$1.22
06 Jun 24	BuyHK$61,000	Wanee Leelalertsuphakun	Individual	50,000	HK$1.22
03 May 24	BuyHK$39,530	Wanee Leelalertsuphakun	Individual	33,500	HK$1.18
02 May 24	BuyHK$130,496	Wanee Leelalertsuphakun	Individual	114,000	HK$1.14
30 Apr 24	BuyHK$7,695	Wanee Leelalertsuphakun	Individual	7,000	HK$1.10
25 Jan 24	BuyHK$68,500	Wanee Leelalertsuphakun	Individual	50,000	HK$1.37
23 Jan 24	BuyHK$40,629	Wanee Leelalertsuphakun	Individual	30,000	HK$1.35
20 Jan 24	BuyHK$123,237	Wanee Leelalertsuphakun	Individual	90,000	HK$1.37
12 Jan 24	BuyHK$65,250	Wanee Leelalertsuphakun	Individual	45,000	HK$1.45
11 Jan 24	BuyHK$29,400	Wanee Leelalertsuphakun	Individual	20,000	HK$1.47
10 Jan 24	BuyHK$75,435	Wanee Leelalertsuphakun	Individual	53,500	HK$1.41

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 950?
Owner Type	Number of Shares	Ownership Percentage
Institutions	41,387,596	7.03%
Individual Insiders	69,337,766	11.8%
VC/PE Firms	83,985,000	14.3%
General Public	150,785,971	25.6%
Private Companies	243,339,010	41.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 21 shareholders own 74.39% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
19.4%	Huby Technology Limited	114,000,625	HK$164.2m	0%	no data
12%	Apta Finance S.A.	70,676,577	HK$101.8m	0%	no data
9.99%	Xiaoyi Li	58,815,266	HK$84.7m	0%	no data
9.25%	GL Capital Group	54,485,000	HK$78.5m	0%	6.29%
5.28%	Gortune International Investment Holding Limited	31,076,999	HK$44.8m	0%	no data
5.01%	Panacea Venture Management Co., Ltd.	29,500,000	HK$42.5m	0%	10.42%
4.98%	UBS Asset Management AG	29,330,425	HK$42.2m	-0.81%	no data
3.68%	Gl Healthcare Investment LP	21,680,488	HK$31.2m	0%	no data
1.43%	Wanee Leelalertsuphakun	8,402,500	HK$12.1m	1.93%	no data
1.09%	Dimensional Fund Advisors LP	6,428,935	HK$9.3m	0%	no data
1%	Aptafin S.p.A.	5,904,321	HK$8.5m	0%	no data
0.89%	Lion River I N.V.	5,239,512	HK$7.5m	0%	1.01%
0.14%	Siu Fong Lee	800,000	HK$1.2m	-0.11%	no data
0.088%	Yau Ching Chan	520,000	HK$748.8k	0%	no data
0.085%	Zuie-Chin Huang	500,000	HK$720.0k	0%	no data
0.051%	Wah Keung Tsim	300,000	HK$432.0k	0%	no data
0.03%	Acadian Asset Management LLC	179,169	HK$258.0k	-20.3%	no data
0.015%	SEI Investments Management Corporation	86,110	HK$124.0k	-27.2%	no data
0.012%	LD Pensions	73,444	HK$105.7k	0%	no data
0.0085%	Fidelity International Ltd	50,000	HK$72.0k	0%	no data
0%	Credit Suisse, Investment Banking and Securities Investments	1	HK$0	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/02 23:46
End of Day Share Price	2025/01/02 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lee's Pharmaceutical Holdings Limited is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jason Cheng	3V Capital Limited
Yue-Kwong Lui	BOCOM International Securities Limited
Chu Wang	Citigroup Inc